Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 20651213.
- Also identified by DOI 10.2214/AJR.09.3437.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this study, we evaluated the feasibility of using dynamic contrast-enhanced MRI (DCE-MRI) subtracted images as a predictor of a decrease in tumor volume in response to chemoradiotherapy in 13 patients with cervical cancer. This study shows that pretreatment tumor nonenhancing fraction assessed with arterial image subtraction inversely predicts the chemoradiation response in cervical cancer.
Medical subject headings
- Chemotherapy, Adjuvant
- Gadolinium DTPA
- Image Enhancement
- Magnetic Resonance Imaging
- Radiotherapy, Adjuvant
- Subtraction Technique
- Uterine Cervical Neoplasms